L

Loestrin

A $63.5 million settlement resolves claims that drug makers conspired to keep generic Loestrin birth control off the market.

ClosedUnited States-wideClaim status: Claim window closedPayout: Closed settlementNo longer claimable

About this settlement

Class members who purchased specific Loestrin birth control products may be eligible to claim compensation from this antitrust settlement.

This settlement resolves allegations that manufacturers conspired to delay generic versions of Loestrin birth control, affecting consumers who purchased certain brands.

Who qualifies

  • Individuals who purchased certain Loestrin birth control products.
  • Class members as defined by the settlement terms.

Closed settlement

Claim status: Claim window closed

See active Settlements

Related settlements

Estée Lauder logo

Estée Lauder

No proof required

Up to $5,000

Claims opening soon

Silk and Great Value logo

Silk and Great Value

Proof required

Up to $300,000

96 days left

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

746 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon

Ticketmaster logo

Ticketmaster

No proof required

Compensation pending

Claims opening soon